Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Retained Earnings: 2015-2024

Historic Retained Earnings for Wave Life Sciences (WVE) over the last 10 years, with Dec 2024 value amounting to -$1.1 billion.

  • Wave Life Sciences' Retained Earnings fell 10.59% to -$1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.3 billion, marking a year-over-year decrease of 10.59%. This contributed to the annual value of -$1.1 billion for FY2024, which is 9.47% down from last year.
  • As of FY2024, Wave Life Sciences' Retained Earnings stood at -$1.1 billion, which was down 9.47% from -$1.0 billion recorded in FY2023.
  • In the past 5 years, Wave Life Sciences' Retained Earnings registered a high of -$683.3 million during FY2020, and its lowest value of -$1.1 billion during FY2024.
  • In the last 3 years, Wave Life Sciences' Retained Earnings had a median value of -$1.0 billion in 2023 and averaged -$1.0 billion.
  • Data for Wave Life Sciences' Retained Earnings shows a maximum YoY fell of 28.11% (in 2020) over the last 5 years.
  • Over the past 5 years, Wave Life Sciences' Retained Earnings (Yearly) stood at -$683.3 million in 2020, then declined by 17.89% to -$805.5 million in 2021, then dropped by 20.09% to -$967.3 million in 2022, then declined by 5.95% to -$1.0 billion in 2023, then decreased by 9.47% to -$1.1 billion in 2024.